Academic Journal
Q1Biochemical Pharmacology
About Biochemical Pharmacology
Biochemical Pharmacology is a scholarly journal published by Elsevier Inc.. SCImago 2025 places it in Q1 with an SJR of 1.687 and an H-index of 234.
Its listed coverage is 1958-2026 and its research categories include Biochemistry (Q1); Pharmacology (Q1). The 2025 dataset reports 660 documents and 9532 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Ion channel regulation and function, Eicosanoids and Hypertension Pharmacology.
Recent Research Articles
Latest publications matched automatically by ISSN.
Finerenone attenuates glomerular fibrosis via inhibiting mesangial SEMA3C in diabetic mice
Yajing Wang, Yingjie Feng, Na Luo, Ling Cao et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118370The regulatory role of non-coding RNAs in taxane resistance of breast cancer
Cuicui Sun, Lingling Lv, Qinzheng Xu, Shuang Wu et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118371A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin
Lucie Fonteneau, Houda Benhelli-Mokrani, Céline Robiou Du Pont, Damien Marquis et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118393Chitosan-selenium nanoparticles prevent retinal ganglion cell apoptosis in glaucoma via activation of the PI3K/Akt/Nrf2 antioxidant axis
Yu-jia Huo, Miao Wei, Xiao Fan, Li-wen Peng et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118416Inflammatory-metabolic coupling in glia: LCN2-PDK axis as molecular mechanism and therapeutic paradigm
Kyoungho Suk
2026-12 · DOI: 10.1016/j.bcp.2026.118407Connexin-43 remodeling drives atrial arrhythmias in hypothyroidism: ranolazine as a potential therapeutic strategy
Emanuel Barbosa dos Santos, Jonathan Ezequiel de Souza Bazilio, Jorge Lucas Teixeira-Fonseca, Jéssica Maria Dantas Araújo Aragão et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118418The MAPK pathway as a pharmacological target to reprogram cancer-associated fibroblasts and disrupt the stromal shield
Masaki Arioka, Fumi Takahashi-Yanaga
2026-12 · DOI: 10.1016/j.bcp.2026.118380Genistein inhibits colorectal cancer progression via regulating the LINC00355/miR-150/SGK1 axis and downstream EGFR/PI3K/AKT and MAPK signaling pathways
Xing Zhou, Jian Qin, Zhongwen Feng, Shiran Qin et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118399From intercellular communication to therapeutic delivery: Mechanistic perspectives of cancer exosomes
RamaRao Malla, Ganji Purnachandra Nagaraju
2026-12 · DOI: 10.1016/j.bcp.2026.118390Targeting PKM2 by (+)-homocrepidine A restrains glycolytic reprogramming and reshapes macrophage fate to alleviate acute lung injury
Rongrong Dong, Yu Yang, Na Luo, Tingting Wang et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118404Wogonoside: Pharmacology, molecular targets and therapeutic potential
Ming Xie, Jia Liu, Rui Pu, Xiang Qiu et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118409UCHL1 attenuates diabetic retinopathy by deubiquitinating and stabilizing NRF2 to suppress oxidative stress-induced retinal vascular endothelial ferroptosis
Sanhua Xu, Jun Huang, Yicang Wang, Yi Shao et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118389DNMT1 is associated with anti-PD-1 resistance and regulates the STAT3/PD-L1–CD8+ T-cell axis in melanoma
Yujia Sun, Chen Chen, Yingjie Wang, Chuanxin Cui et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118392Small-molecule disruption of the TRAF6–Ubc13 protein–protein interaction: targeting noncanonical ubiquitin signaling in inflammation and cancer
Saleh Alkhedhairi
2026-12 · DOI: 10.1016/j.bcp.2026.118402Lipoprotein components of probiotics act as negative regulators of bone metabolism via the dual modulation of osteoclast and osteoblast differentiation
Yeonjin Lim, Bo-Min Kim, Jinsung Park, Cheol-Heui Yun et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118385PHGDH: metabolic enzyme or signaling hub? From broad-spectrum inhibition toward context-adapted therapeutic targeting
Cuicui Sun, Shuang Wu, Zihan Li, Chunjie Huang et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118376Immunopharmacological reprogramming of innate immune memory in Alzheimer’s disease: From microglial priming to therapeutic resilience
Ahmed M. Abdelaziz, Reem M. Eladawy
2026-12 · DOI: 10.1016/j.bcp.2026.118381Drug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies
Hongtu Hu, Suyue Hou, Wenjie Chen, Jijia Hu et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118405Multi-tissue transcriptomic atlas reveals systemic effects of FGF19 on metabolism and immunity
Yang Xiao, Liwen Kuang, Juan He, Xudong Liu et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118384Integrin αVβ3-mediated focal adhesion signaling promotes fibroblast activation during renal fibrosis
Dongdong Wu, Jing Zhao, Xinrui Chang, Yuman Lei et al.
2026-12 · DOI: 10.1016/j.bcp.2026.118401Reviews
Community Reviews
Version History
September 8, 2026 at 12:03 am
September 8, 2026